Hostname: page-component-745bb68f8f-g4j75 Total loading time: 0 Render date: 2025-01-08T16:46:37.429Z Has data issue: false hasContentIssue false
  • English
  • Français

Imipramine (Tofranil) in Depressive States a Controlled Trial with In-Patients

Published online by Cambridge University Press:  08 February 2018

Charles Friedman ,
M. S. De Mowbray  and
Vernon Hamilton
Charles Friedman
Affiliation:
Springfield Hospital. London, S.W.17
M. S. De Mowbray
Affiliation:
Springfield Hospital. London, S.W.17
Vernon Hamilton
Affiliation:
Banstead Hospital, Sutton, Surrey
Get access Rights & Permissions [Opens in a new window]

Extract

A large number of papers has been published in the last two or three years on the use of imipramine in depressive states. Much of this literature has been reviewed by Ball and Kiloh (1959) whose investigations on out-patients represents one of the remarkably few controlled trials that have so far appeared. We feel, therefore, that there is room for a report on another controlled study, this time with in-patients, in which the term “controlled” not only involved the usual “blind” procedures of administering tablets, but also included some of those elementary safeguards of reliability and validity of assessments without which uncertainty must remain concerning the meaning of any findings. Foulds (1958), for example, has presented evidence that uncontrolled investigations have a greater tendency to yield results supporting the hypotheses of investigations than experimentally fully controlled trials. In view of the claims that had been made for the efficacy of imipramine in a number of uncontrolled studies, we were primarily concerned to discover whether or not there existed valid scientific evidence of its value and, if so, in what kinds of depressive illness it appeared to be of most benefit.

Type
Original Articles
Information
Journal of Mental Science , Volume 107 , Issue 450 , September 1961 , pp. 948 - 953
Copyright
Copyright © Royal College of Psychiatrists, 1961 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ball, J. R. B., and Kiloh, L. G., Brit. Med. J., 1959, ii, 1052.CrossRefGoogle Scholar
Foulds, G. A., J. Ment. Sci., 1958, 104, 259.CrossRefGoogle Scholar
Lehman, H. E., et al., Canad. Psychiat. Ass. J., 1959, 4, (Spec. Suppl.), S.38.Google Scholar
Roth, M., ibid., 1959, 4 (Spec. Suppl.), S.32.Google Scholar
Shapiro, M. B., Campbell, C., Harris, A., and Dewsbury, J. P., J. Ment. Sci., 1958, 104, 681.CrossRefGoogle Scholar
Wittenborn, J. R., J. Consult. Psychol., 1951, 15, 290.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.